Smoldering and polarized inflammation in the initiation and promotion of malignant disease / A. Mantovani, F. Balkwill, K.A. Charles. - In: CANCER CELL. - ISSN 1535-6108. - 7:3(2005 Mar), pp. 211-217. [10.1016/j.ccr.2005.02.013]

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

A. Mantovani
Primo
;
2005

Barrett esophagus; DNA polymorphism; Mycobacterium tuberculosis; breast cancer; cancer chemotherapy; cancer growth; cancer radiotherapy; cancer susceptibility; chronic inflammation; clinical trial; colon carcinogenesis; colorectal cancer; drug clearance; gene mutation; human; innate immunity; lymphoma; malignant neoplastic disease; myeloma; nonhuman; opportunistic infection; plasticity; polarization; priority journal; review; rheumatoid arthritis; side effect; tumor associated leukocyte; tumor immunity; I kappa B; acetylsalicylic acid; antineoplastic agent; antioxidant; celecoxib; chemokine receptor antagonist; cyclooxygenase 2 inhibitor; cytokine receptor antagonist; exemestane; immunosuppressive agent; interleukin 6 antibody; nonsteroid antiinflammatory agent; proteasome inhibitor; tumor necrosis factor alpha antibody; zoledronic acid; ASA
Settore MED/04 - Patologia Generale
mar-2005
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/8977
Citazioni
  • ???jsp.display-item.citation.pmc??? 639
  • Scopus 1483
  • ???jsp.display-item.citation.isi??? 1380
social impact